Review of the dietetic and MDT management of Cystic Fibrosis

Simple item page
dc.contributor.authorTwomey, Aoife
dc.date.accessioned2024-09-12T10:32:37Z
dc.date.available2024-09-12T10:32:37Z
dc.date.issued04/09/2024
dc.description.abstractINTRODUCTION: Cystic Fibrosis (CF) is an autosomal recessive disorder due to mutations in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene leading to abnormality of chloride channels in mucus and sweat producing cells. The respiratorysystem (lungs) and digestive system (GIT) are primarily impacted, leading to life threatening complications (Rafeeq and Murad, 2017). Ireland has the highest incidence of CF in the world. Approximately 1 in 19 Irish people are said to 'carry' one copy of the altered gene that causes CF (Cystic Fibrosis Ireland, 2023). More than 1900 mutations of CF have been identified (Rafeeq and Murad, 2017). METHODS: Articles for review were sourced from the academic database PubMed. Results were screened using PICOS criteria, focusing on dietetic management of CF. Papers dating back as far as the 1980’s were included in the review due to their continuing relevance in CF treatment today. RESULTS: Initial database searches identified 61 results, which were then screened for relevance to the objectives of this review. Treatment of CF requires a multi-disciplinary team approach, for which Nutrition and Dietetic management is integral. Lifelong management of CF includes pharmaceutical treatment to manage symptoms, case specific diet and lifestyletherapy, management of complications and co-morbidities, and novel therapies such as CFTR modulators. CONCLUSION: The identification of the faulty CFTR gene that causes CF was an important step in managing the disorder, yet has not led to a cure for the condition. Life expectancy for patients with CF has steadily improved during the last three decades, with medicalmanagement of symptoms and advances in CF therapies. Complications associated with the condition are treated on a case-by-case basis due to complexity of symptoms and individuality of the condition. Dietetic management includes a high calorie, high salt, and high protein diet and routine monitoring for changes in symptoms and nutritional deficiencies.en
dc.description.statusPeer-revieweden
dc.description.versionPublished Versionen
dc.format.mimetypeapplication/pdfen
dc.identifier.citationTwomey, A. (2024) 'Review of the dietetic and MDT management of Cystic Fibrosis', UCC Student Medical Journal, 4, pp. 61-66. https://doi.org/10.33178/SMJ.2024.1.5en
dc.identifier.doihttps://doi.org/10.33178/SMJ.2024.1.5
dc.identifier.endpage66
dc.identifier.issn2737-7237
dc.identifier.journalabbrevUCC SMJ
dc.identifier.journaltitleUCC Student Medical Journalen
dc.identifier.startpage61
dc.identifier.urihttps://journals.ucc.ie/index.php/smj/article/view/4139
dc.identifier.urihttps://hdl.handle.net/10468/16343
dc.language.isoenen
dc.publisherUCC Medical Research and Technology Societyen
dc.rights© 2024, the Author(s). This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.en
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0
dc.subjectCystic fibrosisen
dc.subjectDietetic managementen
dc.subjectCFTR geneen
dc.subjectPhysical activity in cystic fibrosisen
dc.subjectPrevalence of cystic fibrosis in Irelanden
dc.subjectDieteticsen
dc.titleReview of the dietetic and MDT management of Cystic Fibrosisen
dc.typeArticle (peer-reviewed)en
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Review+of+the+Dietetic+and+MDT+Management+of+Cystic+Fibrosis (2).pdf
Size:
165.08 KB
Format:
Adobe Portable Document Format
Description:
Published Version
Download
Collections
UCC Student Medical Journal